Status:
Awaiting development
Technology type:
Medicine
Decision:
Selected
Prioritisation programme:
Medicines evaluation
Rationale:

Deferred appraisal of D5.

Process:
STA Standard
ID number:
12518

Email enquiries

If you have any queries please email TACommD@nice.org.uk

Related links

Timeline

Key events during the development of the guidance:

Date Update
01 July 2026 Awaiting development. Status change linked to topic prioritisation decision being set to Selected
01 July 2026 This is the deferred appraisal of D5. Scoping documents can be found on the record for D5. The appraisal is expected to begin in early July 2026. - Note added to the project documents

For further information on our processes and methods, please see our CHTE processes and methods manual